We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

111 hedge funds and large institutions have $526M invested in Voyager Therapeutics in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

397% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $309K

101% more capital invested

Capital invested by funds: $262M → $526M (+$264M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

30% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 33

1.34% less ownership

Funds ownership: 85.56% → 84.22% (-1.3%)

4% less funds holding

Funds holding: 116 → 111 (-5)

23% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 22

Holders
111
Holders Change
-5
Holders Change %
-4.31%
% of All Funds
2.4%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
43
Reduced
33
Closed
22
Calls
$1.54M
Puts
$309K
Net Calls
+$1.23M
Net Calls Change
+$980K

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$25.4M
2
ClearBridge Investments
ClearBridge Investments
New York
+$4.94M
3
BI
BVF Inc
California
+$4.04M
4
EAM
Erste Asset Management
Austria
+$3.13M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.62M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$16.9M
2
HCM
Highline Capital Management
New York
-$9.06M
3
EAM
Eventide Asset Management
Massachusetts
-$4.1M
4
Millennium Management
Millennium Management
New York
-$3.44M
5
GPP
Great Point Partners
Connecticut
-$3.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
101
Federated Hermes
Pennsylvania
$8K -$43.3K -3,324 -89%
IA
102
IFP Advisors
Florida
$8K -$3.26K -250 -38%
AG
103
Advisor Group
Arizona
$8K +$5.21K +400 New
MAM
104
Meeder Asset Management
Ohio
$6K +$404 +31 +11%
Daiwa Securities Group
105
Daiwa Securities Group
Japan
$3K – – –
MIFH
106
Migdal Insurance & Financial Holdings
Israel
$2K – – –
Group One Trading
107
Group One Trading
Illinois
$2K +$1.3K +100 New
LTFS
108
Ladenburg Thalmann Financial Services
Florida
$2K +$1.3K +100 New
RIA
109
Realta Investment Advisors
Delaware
$2K +$1.3K +100 New
GEA
110
Glen Eagle Advisors
New Jersey
$1.91K -$1.63K -125 -56%
PCM
111
Prelude Capital Management
New York
$1K -$1.07K -82 -52%
EAM
112
Eventide Asset Management
Massachusetts
– -$4.1M -436,000 Closed
GPP
113
Great Point Partners
Connecticut
– -$3.43M -365,132 Closed
Two Sigma Investments
114
Two Sigma Investments
New York
– -$1.32M -140,536 Closed
T. Rowe Price Associates
115
T. Rowe Price Associates
Maryland
– -$1.23M -131,202 Closed
DM
116
Deerfield Management
New York
– -$1.11M -117,647 Closed
HP
117
Harbourvest Partners
Massachusetts
– -$684K -72,726 Closed
Credit Agricole
118
Credit Agricole
France
– -$430K -45,700 Closed
CSS
119
Cubist Systematic Strategies
Connecticut
– -$416K -44,289 Closed
Squarepoint
120
Squarepoint
New York
– -$329K -34,983 Closed
Citadel Advisors
121
Citadel Advisors
Florida
– -$412K -31,619 Closed
BG
122
Bellevue Group
Switzerland
– -$262K -27,900 Closed
TK
123
TIAA Kaspick
Massachusetts
– -$261K -27,775 Closed
TI
124
Trexquant Investment
Connecticut
– -$202K -21,504 Closed
PP
125
Paloma Partners
Connecticut
– -$155K -16,500 Closed
2 3 4
5
6

VYGR Hedge Fund Activity: Q1 2019 in Review

111 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2019, worth a combined $526M — up 101% from $262M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VYGR and 17 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 43 added.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $25.4M. The largest seller was Armistice Capital, cutting an estimated $16.9M.

  • 111 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2019, down from 116 in Q4 2018.
  • Funds reported $526M of Voyager Therapeutics stock for Q1 2019, up 101% quarter-over-quarter.
  • 17 funds opened new Voyager Therapeutics positions in Q1 2019 and 22 closed out, a net change of -5 holders.
  • The largest Voyager Therapeutics buyer in Q1 2019 was PFM Health Sciences, an estimated $25.4M added.
  • The largest Voyager Therapeutics seller in Q1 2019 was Armistice Capital, an estimated $16.9M sold.

Based on aggregated 13F filings for Q1 2019.